Nilotinib for First-line Newly Diagnosed CML-CP Patients

Conditions:   Chronic Myeloid Leukemia, Chronic Phase;   Nilotinib Intervention:   Drug: Nilotinib Sponsor:   Shenzhen Second People's Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials